Skip to main content

Table 1 Baseline characteristics of patients.

From: Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum

 

SP (n = 50)

AQ (n = 50)

Treatment outcome

TF

ACPR

TF

ACPR

PCR un-corrected, N (%)

35 (70)

15 (30)

22 (44)

28 (56)

PCR corrected, N (%)

34 (68)

16 (32)

19 (38)

31 (62)

Median age (months, CI)

31.5 (25.3–36)

27.5 (19–41.4)

24 (19.4–43.9)

32 (23.5–38.5)

Females (%)

31.6

38.7

41.2

68.7

Geometric mean parasite density, day0 (/ul. CI)

39.810 (28.184–56.234)*

17.865 (8.511–37.153)

28.840 (14.256–57.544)

32.359 (22.387–43.651)

Mean haemoglobin day0 (PCV, SD)

29.4 (4.8)

29.6 (5.8)

28.6 (6.5)

30.7 (5.1)

Mean temperature day0 (°C. SD)

38.8 (0.9)

38.5 (0.6)

38.5 (0.9)

39.1 (0.8)

Alpha+-thalassaemia, %

33.4

27.6

42.9

35.7

HbAS, %

15.2

12.5

10.4

9.7

  1. TF: Parasitological or clinical treatment failure, ACPR: Adequate clinical and parasitological response. SP: sulphadoxine-pyrimethamine, AQ: amodiaquine. * Significantly different from value for parasite density in ACPR group as calculated by Student's t test.